We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Research into Ischaemic heart disease seeks to prevent the disease’s progression, and improve treatment and patient prognosis.
In attempts to retard the evolution of the disease, studies have been designed with medicines that can alter HDL and LDL cholesterol levels (good and bad cholesterol, respectively) or improve the management and control of diabetes and high blood pressure.
To improve treatment outcomes, studies have been conducted with new devices that can be used without “opening the chest”, such as fully biodegradable stents, which could represent a revolutionary advance in the next few years.
Similarly, researchers are investigating the possibility of using cell therapy (stem cells) to regenerate the dead portion of heart muscle caused by an infarction. The results of these studies are expected to be published in the next 3–5 years.
We are sorry, we are working to improve PortalCLÍNIC. Help us become better, tell us why
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Manel Sabaté TenasCardiologistCardiology Department
Marta Farrero TorresCardiologistCardiology Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.